LeMaitre Vascular (LMAT) Tops Q3 EPS by 7c
LMAT Hot Sheet
Financial Fact:Research and development: 1.14M
Today's EPS Names:
TARO, BRLI, TLB, More
LeMaitre Vascular, Inc. (NASDAQ: LMAT) reports Q3 EPS of $0.08, 7 cents better than the analyst estimate of $0.01. Revenue for the quarter was $13.3 million, which compares to the estimate of $11.80 million.
Reaffirms outlook.
Reaffirms outlook.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
